Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Pneumococcal Vaccine Clinical Trial

Official title:
Phase 2, Randomized, Active-Controlled, Double-Blind Trial Evaluating The Safety, Tolerability, And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine In Healthy Infants Given With Routine Pediatric Vaccinations In Korea

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC), relative to a 7-valent pneumococcal conjugate vaccine (7vPnC) when given concomitantly with routine vaccines in Korea.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Pneumococcal Vaccine

Clinical Trial Details

NCT number	NCT00689351
Study type	Interventional
Source	Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status	Completed
Phase	Phase 2
Start date	June 2008
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01521897` - Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)	N/A
Completed	`NCT03098628` - Trial of Simplified Pneumococcal Vaccination in Vietnam II	Phase 2/Phase 3
Active, not recruiting	`NCT06337643` - A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine	Phase 1
Recruiting	`NCT03046134` - Burden of Hospitalized Pneumonia in Korea COPD Population	N/A
Recruiting	`NCT06181656` - Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Completed	`NCT05721092` - Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India
Completed	`NCT05788510` - Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy